Wegovy: pill or injection — which form is right for you?

Wegovy exists in two licensed UK forms: a once-weekly subcutaneous injection and a once-daily oral tablet approved by the MHRA in June 2026.
Both forms contain semaglutide, a GLP-1 receptor agonist that reduces appetite and slows the rate at which the stomach empties.
The tablet requires a specific morning routine (empty stomach, small sip of water, nothing else for at least 30 minutes) because absorption is easily disrupted.
Neither form is available without a prescription; a GPhC-registered prescriber must assess your health, weight and medical history before either is dispensed.

Wegovy is now available in both forms. Since June 2026, the MHRA has approved Wegovy as an oral tablet — making it the first GLP-1 weight-loss medicine licensed in the UK you can swallow rather than inject. The weekly injection has been available in the UK since 2023. Both contain semaglutide; the choice between them is a clinical one worth thinking through carefully. These are prescription-only medicines, which means a prescriber assesses whether either option suits your circumstances before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Tablet or injection: the factors that actually matter when choosing

What the injection involves and who tends to prefer it

The Wegovy injection is a pre-filled pen you use once a week, injecting into the abdomen, thigh or upper arm. Treatment starts at 0.25 mg and is increased gradually by a prescriber, typically in four-week steps, up to a standard maintenance dose of 2.4 mg. The MHRA also approved a higher 7.2 mg dose in January 2026, with a dedicated single-dose pen confirmed in April of that year, though which specific dose or pen format is available to you is confirmed during a clinical consultation, not assumed in advance.

For many people, once-weekly is simply easier to build a habit around than once-daily. There is no food or drink restriction tied to the injection timing, you can do it after dinner, on a Sunday morning, whenever it fits your week. The pen must be kept refrigerated, which is worth bearing in mind if you travel a lot or your routine is unpredictable. A comparison of the semaglutide pill and injection covers the storage and routine differences in more detail.

The trial evidence for the injection is well-established. In the STEP 1 study, published in the New England Journal of Medicine, adults using 2.4 mg semaglutide weekly lost an average of around 15% of their body weight over 68 weeks alongside lifestyle changes. Some people are put off by the idea of self-injecting; most find the pen straightforward after the first use, but it is a fair thing to weigh up.

What the tablet involves and what the evidence shows

The Wegovy tablet was approved by the MHRA on 11 June 2026, making the UK the first country in Europe to licence an oral GLP-1 medicine for weight management. It starts at 1.5 mg daily and increases through 4 mg and 9 mg to a 25 mg maintenance dose, with at least a month at each level. That escalation sits entirely in your prescriber's hands, the schedule is theirs to manage based on how you tolerate each stage.

Taking it correctly matters more than it might sound. Oral semaglutide is absorbed poorly unless the stomach is completely empty: first thing in the morning, a small sip of plain water only (roughly up to 120 ml), then nothing (no coffee, no food, no other medicines) for at least 30 minutes. Miss that window and you may absorb very little of the dose. If your mornings are rushed or unpredictable, that is worth being honest about before you choose this route. For a closer look at how semaglutide tablets work day to day, that page goes into the practical detail.

In the OASIS 4 phase-3 trial (64 weeks, 307 adults with obesity or overweight plus at least one weight-related condition, no diabetes), participants lost an average of around 13.6% of their body weight compared with around 2.4% on placebo. Among those who stuck fully to treatment, the average was closer to 17%, though that figure only holds for people with full adherence, and most real-world results sit below it. On the upside, the tablet needs no refrigeration, which makes it genuinely travel-friendly in a way the injection is not.

Where the two forms differ on side effects and what to watch for

Both forms share a broadly similar side-effect profile because the active ingredient is the same. Nausea, loose stools, constipation, indigestion and tiredness are the most commonly reported, and they tend to be most noticeable in the first few weeks or after a dose increase, then settle for most people. The NHS medicines page for semaglutide has a full list worth reading before you start either form.

The tablet showed a notably higher rate of gastrointestinal side effects in the OASIS 4 trial: around 74% of tablet users reported them, compared with around 42% on placebo. That is higher than the injection trial rates, and it is thought to relate partly to how oral semaglutide is absorbed. It does not mean the tablet is more dangerous (for most people the effects were described as mild to moderate and temporary) but it is a real difference to factor in if your stomach is already sensitive.

One thing the oral versus injection question does not always surface: both forms carry a prescribing note about pancreatitis. Seek urgent medical attention for any severe, persistent stomach pain that spreads toward the back, with or without vomiting, this applies regardless of which form you use. If you are on oral contraceptives and switching to the injection, there is a specific guidance point about tirzepatide and pill absorption, though for semaglutide the NHS has not identified an equivalent concern. Worth discussing either way at your consultation.

How a prescriber helps you land on the right answer

The honest answer to whether Wegovy comes as pills or an injection is that it depends on you specifically, your daily routine, how you feel about injecting, your travel plans, your medical history and which form your prescriber judges appropriate. Some people starting fresh will have a clear preference; others genuinely do not mind and just want the most effective option for their situation. People already established on the 2.4 mg weekly injection may, subject to clinical assessment, move directly to the 25 mg tablet rather than repeating the full titration from scratch.

At nume, a GPhC-registered Independent Prescriber reads every consultation personally (a real clinician, not software) on the day you submit it. They consider both the clinical picture and what you've told them about your lifestyle. You can explore the full range of weight-loss treatments we support before deciding, or go straight to the consultation if you already know roughly what you're after. If you tend to place orders at the start of the month when finances line up, it is worth knowing that orders placed by 12pm Monday to Friday are dispatched the same day once clinically approved, with free next-working-day tracked delivery by DPD. The cost of the tablet versus the injection is another factor some people ask about, and if you are still weighing up whether the Wegovy oral or injection route suits you better, that page works through the practical considerations before you decide. Wegovy tablet pricing is covered separately. Our clinical team is here if you want to understand which form suits your circumstances before committing. Check your eligibility with a free consultation whenever you are ready.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions